Argenx
ARGX
#418
Rank
NZ$105.71 B
Marketcap
NZ$1,681
Share price
1.77%
Change (1 day)
8.74%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

P/S ratio for Argenx (ARGX)

P/S ratio as of November 2026 (TTM): 10.0

According to Argenx 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.93. At the end of 2023 the company had a P/S ratio of 18.4.

P/S ratio history for Argenx from 2022 to 2021

PS ratio at the end of each year

Year P/S ratio Change
202318.4-63.94%
202251.0-17.82%
202162.1
201978.5-34.86%
2018121202.52%
201739.9
201425.2